Nasivara (Beclometasone Dipropionate)

Beclometasone dipropionate, the active ingredient in Nasivara, is a corticosteroid presented as a nasal spray for nasal administration. It is used to treat inflammatory nasal conditions such as allergic rhinitis and other nasal mucosal inflammations in adults and children. The molecule works locally in the nose to reduce swelling, itching and discharge, providing symptom relief without significant systemic exposure.

GNH USA supplies Nasivara as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nasivara is a nasal corticosteroid that acts on the inflammatory pathways of the nasal mucosa. It is indicated for: - Allergic rhinitis: reduces nasal congestion, sneezing, itching and rhinorrhea. - Seasonal or perennial nasal allergy: controls symptoms triggered by pollen, dust or animal dander. - Post‑operative nasal inflammation: helps maintain nasal patency after sinus surgery or polypectomy.

Common Side Effects: - Nasal irritation or burning sensation. - Epistaxis (nosebleeds). - Headache. - Throat irritation or dryness. - Altered taste or unpleasant taste. - Cough.

Serious or Rare Side Effects: - Fungal infection of the nasal mucosa. - Cataracts or glaucoma with prolonged use. - Adrenal suppression when used at high doses. - Severe or persistent nosebleeds. - Anaphylactic or severe allergic reaction. - Nasal septum perforation (very rare).

Before using Nasivara, consider the following precautions: - Assess infection risk: avoid use in active nasal or sinus infections unless directed by a clinician. - Monitor for ocular effects: advise patients to report visual changes that could indicate cataracts or glaucoma. - Evaluate systemic steroid exposure: limit concurrent high‑dose oral or injectable corticosteroids. - Use in pregnancy and lactation only if clearly needed and prescribed by a healthcare professional. - Pediatric use: follow pediatric dosing recommendations and monitor growth. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Beclometasone dipropionate may interact with other medicines as follows:

Major Interactions (Avoid): - Systemic corticosteroids: concurrent high‑dose oral or injectable steroids increase risk of adrenal suppression. - Strong CYP3A4 inhibitors (e.g., ketoconazole, itraconazole): may raise systemic exposure of the nasal steroid.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., fluconazole): may modestly increase systemic levels. - HIV protease inhibitors (e.g., ritonavir): require monitoring for systemic effects. - Nasal decongestants: combined use may increase local irritation. - Antihistamines: monitor for additive sedation if combined with sedating antihistamines.